Bioengineering in renal transplantation: technological advances and novel options
End-stage kidney disease (ESKD) is one of the most prevalent diseases in the world with significant morbidity and mortality. Current modes of renal replacement therapy include dialysis and renal transplantation. Although dialysis is an acceptable mode of renal replacement therapy, it does have its shortcomings, which include poorer life expectancy compared with renal transplantation, risk of infections and vascular thrombosis, lack of vascular access and absence of biosynthetic functions of the kidney. Renal transplantation, in contrast, is the preferred option of renal replacement therapy, with improved morbidity and mortality rates and quality of life, compared with dialysis. Renal transplantation, however, may not be available to all patients with ESKD. Some of the key factors limiting the availability and efficiency of renal transplantation include shortage of donor organs and the constant risk of rejection with complications associated with over-immunosuppression respectively. This review focuses chiefly on the potential roles of bioengineering in overcoming limitations in renal transplantation via the development of cell-based bioartificial dialysis devices as bridging options before renal transplantation, and the development of new sources of organs utilizing cell and organ engineering.
KeywordsEnd-stage kidney disease Dialysis Renal transplantation Bioartificial dialysis devices Cell and organ engineering
Compliance with ethical standards
Conflicts of interests
The authors declare that they have no conflicts of interest.
- 1.National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationGoogle Scholar
- 2.United States Renal Data System 2016 (2016) USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, BethesdaGoogle Scholar
- 3.United States Renal Data System 2015 (2015) USRDS annual data report: epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, BethesdaGoogle Scholar
- 4.ERA-EDTA Registry (2016) ERA-EDTA Registry Annual Report 2014. Academic Medical Center, Department of Medical Informatics, Amsterdam, the NetherlandsGoogle Scholar
- 14.Goldstein SL, Graham N, Warady BA, Seikaly M, McDonald R, Burwinkle TM, Limbers CA, Varni JW (2008) Measuring health-related quality of life in children with ESRD: performance of the generic and ESRD-specific instrument of the Pediatric Quality of Life Inventory (PedsQL). Am J Kidney Dis 51:285–297CrossRefPubMedGoogle Scholar
- 27.Kolff WJ, Berk HTJ (1943) De kunstmatige nier. Een dialysator met groot oppervlak. Ned Tijdschr Geneeskd 87:1684Google Scholar
- 28.Broers H (2006) Inventor for life, the story of W. J. Kolff, father of artificial organs. B&Vmedia, KampenGoogle Scholar
- 29.Kolff W (1946) De kunstmatige nier. Kok, KampenGoogle Scholar
- 45.Http://awak.com/news/press/AWAK_PRESS_RELEASE_23052014.pdf. Accessed on 26 September 2016.
- 65.Esteban MA, Wang T, Qin B, Yang J, Qin D, Cai J, Li W, Weng Z, Chen J, Ni S, Chen K, Li Y, Liu X, Xu J, Zhang S, Li F, He W, Labuda K, Song Y, Peterbauer A, Wolbank S, Redl H, Zhong M, Cai D, Zeng L, Pei D (2010) Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6:71–79CrossRefPubMedGoogle Scholar
- 77.Hull CW (1986) Apparatus for production of three-dimensional objects by stereolithography. US4575330 A (Google Patents, 1986)Google Scholar